Teva’s DuoResp Spiromax receives EC marketing authorization for treatment of … – News-Medical.net

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of
News-Medical.net
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced today that the European Commission has granted marketing authorization for DuoResp Spiromax® for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) …
Teva Gets Approval To Market DuoResp Spiromax In EuropeRTT News

all 2 news articles »

View full post on asthma – Google News

Scientists identify enzyme that could be a useful target in treating asthma … – News-Medical.net

Scientists identify enzyme that could be a useful target in treating asthma
News-Medical.net
In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.

and more »

View full post on asthma – Google News

Scientists develop “3D” method to test asthma, allergy medications that … – News-Medical.net

Scientists develop "3D" method to test asthma, allergy medications that
News-Medical.net
In a study published in ACS' journal Molecular Pharmaceutics, scientists report that they've developed a simple, "3D" laboratory method to test asthma and allergy medications that mimics what happens in the body, which could help reduce the need for …

View full post on asthma – Google News

Preterm birth may increase risk of asthma and wheezing disorders during … – News-Medical.net


Headlines & Global News

Preterm birth may increase risk of asthma and wheezing disorders during
News-Medical.net
The findings are based on a systematic review and meta-analysis of 30 studies that investigated the association between preterm birth and asthma/wheezing disorders among 1.5 million children. These studies were conducted between 1995 and the present, 
Pre-term Birth Increases Risk Of Asthma By 70 PercentHeadlines & Global News

all 9 news articles »

View full post on asthma – Google News

Specific protein has vital role in controlling symptoms of allergic asthma … – News-Medical.net

Specific protein has vital role in controlling symptoms of allergic asthma
News-Medical.net
An enzyme that helps maintain immune system function by "throwing away" a specific protein has a vital role in controlling symptoms of allergic asthma, new research in mice suggests. The finding suggests that this enzyme, called Cbl-b, could be a
Researchers find potential target for drug to treat allergic asthmaScience Codex

all 4 news articles »

View full post on asthma – Google News

Asthma drug accelerates desensitization in patients with food allergies to … – News-Medical.net


Science Codex

Asthma drug accelerates desensitization in patients with food allergies to
News-Medical.net
An asthma drug accelerates the process of desensitizing patients with food allergies to several foods at the same time, a new study by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford shows.
Food allergy nearly doubles among black childrenEurekAlert (press release)
New Findings of the Benefits of Allergy Immunotherapy Show Implications for DigitalJournal.com
Cases of food allergy 'have doubled in black children'Medical News Today
MedPage Today –Times of India
all 13 news articles »

View full post on asthma – Google News

Atopix reports positive results from Phase IIb asthma study with OC459 compound – News-Medical.net

Atopix reports positive results from Phase IIb asthma study with OC459 compound
News-Medical.net
Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma 

and more »

View full post on asthma – Google News

Phase III studies show tiotropium delivered via Respimat inhaler proves … – News-Medical.net

Phase III studies show tiotropium delivered via Respimat inhaler proves
News-Medical.net
Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities. These data were presented at 

View full post on asthma – Google News

Researchers examine what dosages of asthma medications works best in … – News-Medical.net

Researchers examine what dosages of asthma medications works best in
News-Medical.net
The University of Illinois at Chicago has received funding from the National Institutes of Health to determine what combination and dosages of asthma medications works best to manage asthma in African Americans, who suffer much higher rates of serious 

and more »

View full post on asthma – Google News